GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+70.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$287M
AUM Growth
-$23.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1 +$11.8M
2 +$8.11M
3 +$6.41M
4
KRRO icon
Korro Bio
KRRO
+$5.53M
5
SYRE icon
Spyre Therapeutics
SYRE
+$5.07M

Top Sells

1 +$8.99M
2 +$6.65M
3 +$5.92M
4
TGTX icon
TG Therapeutics
TGTX
+$5.19M
5
AXSM icon
Axsome Therapeutics
AXSM
+$4.44M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGMT icon
51
Sagimet Biosciences
SGMT
$428M
$770K 0.27%
225,000
ITCI
52
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$685K 0.24%
+10,000
MGNX icon
53
MacroGenics
MGNX
$257M
$638K 0.22%
+150,000
PMVP icon
54
PMV Pharmaceuticals
PMVP
$66.1M
$608K 0.21%
375,000
-300,000
PTCT icon
55
PTC Therapeutics
PTCT
$5.94B
$581K 0.2%
+19,000
RVNC
56
DELISTED
Revance Therapeutics, Inc.
RVNC
$578K 0.2%
225,000
-225,000
NTLA icon
57
Intellia Therapeutics
NTLA
$1.87B
$560K 0.19%
25,000
ANTX icon
58
AN2 Therapeutics
ANTX
$152M
$472K 0.16%
219,331
CTMX icon
59
CytomX Therapeutics
CTMX
$723M
$366K 0.13%
300,000
-300,000
ALT icon
60
Altimmune
ALT
$574M
-250,000
AQST icon
61
Aquestive Therapeutics
AQST
$492M
-702,941
ATXS
62
DELISTED
Astria Therapeutics
ATXS
-115,000
JBIO
63
Jade Biosciences
JBIO
$928M
-6,429
COGT icon
64
Cogent Biosciences
COGT
$5.62B
-450,000
EYPT icon
65
EyePoint Inc
EYPT
$1.08B
-90,000
GERN icon
66
Geron
GERN
$770M
-800,000
GPCR icon
67
Structure Therapeutics
GPCR
$2.66B
-75,000
KALV icon
68
KalVista Pharmaceuticals
KALV
$1.43B
-200,000
QURE icon
69
uniQure
QURE
$1.71B
-165,000
RARE icon
70
Ultragenyx Pharmaceutical
RARE
$2.2B
-20,000
RAPT
71
DELISTED
RAPT Therapeutics
RAPT
0
XBI icon
72
State Street SPDR S&P Biotech ETF
XBI
$7.96B
0
DCPH
73
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-176,513
MRNS
74
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-285,000
LRMR icon
75
Larimar Therapeutics
LRMR
$355M
-210,603